Clinical Trial Shows Promise for Next-Gen Psychedelic Treatment
A biopharmaceutical company this week unveiled the results of a clinical trial it says showcases the potential of psychedelics as a mental health treatment. The findings come via Cybin, a Canadian company “committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options.” According to the company, the results centered around CYB003, […]